BIO Bio-Rad Laboratories, Inc. Stock Quote

BIO [NYSE]

Index	S&P 500	P/E	3.40	EPS (ttm)	220.42	Insider Own	1.80%	Shs Outstand	29.81M	Perf Week	-3.49%
Market Cap	22.29B	Forward P/E	54.23	EPS next Y	13.82	Insider Trans	-2.79%	Shs Float	21.49M	Perf Month	-4.98%
Income	6.66B	PEG	0.19	EPS next Q	3.50	Inst Own	79.90%	Short Float	2.97%	Perf Quarter	-7.86%
Sales	2.98B	P/S	7.48	EPS this Y	116.60%	Inst Trans	0.03%	Short Ratio	5.43	Perf Half Y	28.91%
Book/sh	514.27	P/B	1.46	EPS next Y	-11.18%	ROA	43.00%	Target Price	918.75	Perf Year	40.09%
Cash/sh	44.96	P/C	16.67	EPS next 5Y	17.80%	ROE	56.20%	52W Range	521.40 - 832.70	Perf YTD	28.58%
Dividend	-	P/FCF	33.45	EPS past 5Y	101.00%	ROI	-6.90%	52W High	-9.98%	Beta	0.86
Dividend %	-	Quick Ratio	2.90	Sales past 5Y	4.70%	Gross Margin	57.90%	52W Low	43.76%	ATR	19.73
Employees	8000	Current Ratio	3.80	Sales Q/Q	15.40%	Oper. Margin	18.70%	RSI (14)	47.46	Volatility	2.38% 2.57%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	197.80%	Profit Margin	-	Rel Volume	0.70	Prev Close	750.17
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Oct 28 AMC	Payout	0.00%	Avg Volume	117.48K	Price	749.56
Recom	1.50	SMA20	-1.33%	SMA50	-0.64%	SMA200	10.60%	Volume	82,404	Change	-0.08%

Jan-08-20

Initiated

Wells Fargo

Overweight

$430

Jan-07-20

Initiated

Citigroup

Buy

$450

Oct-17-18

Initiated

Goldman

Buy

$350

Sep-20-18

Initiated

Morgan Stanley

Equal-Weight

$335

Feb-16-18

Downgrade

CL King

Buy → Neutral

Jul-13-17

Initiated

Wells Fargo

Outperform

Jun-28-17

Upgrade

Deutsche Bank

Hold → Buy

$220 → $255

Jan-18-17

Initiated

Deutsche Bank

Hold

$195

Oct-13-16

Initiated

CL King

Buy

May-06-15

Reiterated

Jefferies

Buy

$150 → $165

Dec-18-09

Initiated

Maxim Group

Buy

$125

Nov-06-09

Initiated

Jefferies & Co

Buy

$130

Jul-17-09

Initiated

Soleil

Buy

$91

Sep-26-07

Initiated

Banc of America Sec

Buy

$110

Feb-23-07

Downgrade

Robert W. Baird

Outperform → Neutral

$83 → $76

Nov-29-21 01:34PM	Top Healthcare Stocks for December 2021 Investopedia
Nov-25-21 08:59AM	Bio Rad (BIO) Grows Internationally on New Product Launches Zacks
07:16AM	Here's Why You Should Invest in Bio-Rad (BIO) Stock Now Zacks
Nov-22-21 11:05AM	Is Bio-Rad Laboratories (BIO) Outperforming Other Medical Stocks This Year? Zacks
Nov-15-21 08:46AM	10 Healthcare Stocks to Buy According to John Rogers Ariel Investments Insider Monkey
Nov-11-21 10:46AM	Here's Why You Should Add Chemed (CHE) to Your Portfolio Now Zacks
Nov-04-21 08:50AM	Recent Price Trend in Bio-Rad (BIO) is Your Friend, Here's Why Zacks
Oct-29-21 10:37AM	Bio-Rad (BIO) Q3 Earnings Surpass Estimates, 2021 View Raised Zacks
Oct-28-21 09:01PM	Bio-Rad Laboratories, inc (BIO) Q3 2021 Earnings Call Transcript Motley Fool
05:55PM	Bio-Rad Laboratories (BIO) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:15PM	Bio-Rad Reports Third-Quarter 2021 Financial Results Business Wire
Oct-27-21 07:01AM	Is Now The Time To Look At Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)? Simply Wall St.
Oct-22-21 10:12AM	Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-21-21 03:03PM	Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-20-21 10:13AM	Here's Why You Should Retain Bio-Rad (BIO) Stock For Now Zacks
Oct-19-21 09:25AM	11 Best Genomic Stocks to Buy Now Insider Monkey
Oct-15-21 08:00AM	Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021 Business Wire
Oct-12-21 11:12AM	Hedge Funds Arent Crazy About Bio-Rad Laboratories, Inc. (BIO) Anymore Insider Monkey
Sep-30-21 01:10PM	Bio Rad (BIO) Global Growth Strong, Expenses Continue to Rise Zacks
Sep-18-21 10:34AM	10 Healthcare Stocks to Buy According to Mario Gabelli Insider Monkey
Sep-16-21 12:00PM	Bio-Rad (BIO) Upgraded to Strong Buy: Here's Why Zacks
Sep-14-21 12:00PM	Bio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know Zacks
Sep-13-21 08:19AM	Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Now Zacks
Sep-09-21 08:21AM	HealthEquity (HQY) Q2 Earnings & Revenues Beat Estimates Zacks
Sep-03-21 09:52AM	Cooper Companies (COO) Q3 Earnings & Revenues Beat Estimates Zacks
Sep-02-21 09:08AM	Patterson Companies (PDCO) Q1 Earnings & Revenues Top Estimates Zacks
Aug-31-21 08:50AM	What Makes Bio-Rad (BIO) a Good Fit for "Trend Investing" Zacks
08:00AM	Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference Business Wire
Aug-30-21 10:31AM	Catalent's (CTLT) Q4 Earnings Top Estimates, Margins Rise Zacks
Aug-27-21 08:17AM	Cooper Companies (COO) to Post Q3 Earnings: What's in Store? Zacks
Aug-26-21 09:34AM	What's in Store for Patterson Companies' (PDCO) Q1 Earnings? Zacks
Aug-24-21 09:05AM	Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Up Zacks
Aug-21-21 07:19AM	This Unknown Biotech Has a Secret Weapon for Outsized Returns Motley Fool
Aug-19-21 08:46AM	5 Stocks With Recent Price Strength Amid Robust Reopening Zacks
Aug-18-21 09:34AM	Alcon (ALC) Q2 Earnings Top Estimates, 2021 Guidance Up Zacks
Aug-17-21 10:30AM	Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It? Zacks
Aug-12-21 09:57AM	Accuray (ARAY) Posts In-Line Q4 Earnings, Beats on Revenues Zacks
Aug-11-21 12:20PM	Surging Earnings Estimates Signal Upside for Bio-Rad (BIO) Stock Zacks
09:01AM	Inari Medical (NARI) Q2 Earnings Lag, Revenues Top Estimates Zacks
Aug-10-21 09:57AM	ShockWave Medical (SWAV) Q2 Earnings, Revenues Top Estimates Zacks
09:53AM	Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Aug-09-21 01:00PM	Allscripts' (MDRX) Shares Up Following Q2 Earnings Beat Zacks
09:01AM	Glaukos (GKOS) Stock Gains 0.1% Following Lower Loss in Q2 Zacks
08:50AM	What Makes Bio-Rad (BIO) a Good Fit for "Trend Investing" Zacks
Aug-06-21 01:02PM	AMN Healthcare (AMN) Q2 Earnings Beat Estimates, Margins Up Zacks
12:39PM	Nevro (NVRO) Q2 Earnings Surpass Estimates, Revenues Lag Zacks
12:13PM	Quidel (QDEL) Q2 Earnings Fall Shy of Estimates, Margins Down Zacks
Jul-30-21 10:22AM	Bio-Rad (BIO) Q2 Earnings Top Estimates, 2021 View Raised Zacks
01:32AM	Bio-Rad Laboratories, inc (BIO) Q2 2021 Earnings Call Transcript Motley Fool
Jul-29-21 05:35PM	Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates Zacks
04:15PM	Bio-Rad Reports Second-Quarter 2021 Financial Results Business Wire
Jul-27-21 12:27PM	Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations Business Wire
06:30AM	10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad GlobeNewswire
Jul-23-21 07:01AM	Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-22-21 03:03PM	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: Should You Buy? Zacks
Jul-14-21 04:15PM	Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021 Business Wire
Jul-06-21 10:59AM	Bio-Rad (BIO)-Seegene Pact to Provide Diagnostic Suit In U.S. Zacks
Jun-30-21 05:00PM	Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products Business Wire
Jun-24-21 04:48PM	10 Medical Device Stocks for 2021 Insider Monkey
Jun-21-21 11:51AM	Hedge Funds Are Nibbling On Bio-Rad Laboratories, Inc. (BIO) Insider Monkey
08:00AM	Bio-Rad Launches Its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit for COVID-19 Wastewater Testing Business Wire
Jun-18-21 09:58AM	Obamacare survives: what it means for the future of health care Yahoo Finance Video
May-29-21 04:11PM	Top Stocks for June 2021 Investopedia
May-20-21 08:30AM	Bio-Rad to Participate at Jefferies Virtual Healthcare Conference Business Wire
May-10-21 05:13PM	Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)? Insider Monkey
11:11AM	Why I Relish Low-Debt Stocks GuruFocus.com
Apr-30-21 09:29AM	Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Guidance Up Zacks
05:31AM	Bio-Rad Laboratories Inc (BIO) Q1 2021 Earnings Call Transcript Motley Fool
02:19AM	Is It Too Late To Consider Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)? Simply Wall St.
Apr-29-21 05:45PM	Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates Zacks
04:15PM	Bio-Rad Reports First-Quarter 2021 Financial Results Business Wire
Apr-28-21 05:32PM	What Investors Need to Know About 10x Genomics Motley Fool
Apr-26-21 08:09AM	BioRad (BIO) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-22-21 12:33PM	Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-15-21 08:30AM	Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021 Business Wire
Apr-13-21 09:36AM	Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On Zacks
Apr-05-21 08:37AM	Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day Zacks
Apr-01-21 09:18AM	COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks Zacks
Mar-29-21 03:44PM	Is Bio-Rad (BIO) Stock A Buy or Sell? Insider Monkey
Mar-26-21 12:24PM	Analysts See Plenty of Potential for 10x Genomics GuruFocus.com
08:16AM	The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab Zacks
Mar-22-21 06:18PM	3 Health Care Stocks Trading Below Graham's Valuation GuruFocus.com
Mar-15-21 07:31AM	Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio Zacks
Mar-13-21 11:30AM	Why Is Bio-Rad (BIO) Down 13% Since Last Earnings Report? Zacks
Mar-11-21 10:45AM	3 High-Quality Picks for the Value Investor GuruFocus.com
Mar-05-21 04:16PM	Bio-Rad to Participate in Barclays Global Healthcare Conference 2021 Business Wire
Feb-22-21 04:15PM	Bio-Rad to Participate in Citis 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Business Wire -5.25%
Feb-12-21 09:19AM	Bio-Rad (BIO) Q4 Earnings Surpass Estimates, Margins Rise Zacks
05:31AM	Bio-Rad Laboratories Inc (BIO) Q4 2020 Earnings Call Transcript Motley Fool
05:29AM	Bio-Rad 4Q Sales Top Estimates Driven By COVID-19 Demand SmarterAnalyst
Feb-11-21 05:45PM	Bio-Rad Laboratories (BIO) Q4 Earnings and Revenues Surpass Estimates Zacks
04:52PM	Bio-Rad Laboratories: Q4 Earnings Insights Benzinga
04:20PM	Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results Business Wire
Feb-10-21 10:30AM	Earnings Preview: Bio-Rad Laboratories Benzinga
09:12AM	Medical Products' Feb 11 Earnings Roster: DXCM, LH & More Zacks
Feb-08-21 09:51AM	A Look Into Healthcare Sector Value Stocks Benzinga
Feb-05-21 09:53AM	Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-04-21 04:10PM	10 Cheap Healthcare Stocks To Buy Now Insider Monkey
Jan-25-21 04:15PM	Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021 Business Wire
Jan-21-21 08:00AM	Bio-Rad's CEO Just Shared His Four-Part Plan For Success Investor's Business Daily

Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TUMOLO ANNETTE	Executive Vice President	Nov 12	Option Exercise	250.21	4,800	1,201,014	9,393	Nov 15 10:55 AM
TUMOLO ANNETTE	Executive Vice President	Nov 12	Sale	750.05	4,800	3,600,240	4,593	Nov 15 10:55 AM
TUMOLO ANNETTE	Executive Vice President	Nov 11	Option Exercise	386.82	1,546	598,029	6,139	Nov 15 10:55 AM
TUMOLO ANNETTE	Executive Vice President	Nov 11	Sale	749.00	1,546	1,157,958	4,593	Nov 15 10:55 AM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 07	Option Exercise	92.56	40,000	3,702,220	336,786	Sep 09 09:39 AM
Crowley Michael	EVP, GBL Commercial Operations	Sep 07	Option Exercise	0.00	600	0	5,371	Sep 09 09:38 AM
TUMOLO ANNETTE	Executive Vice President	Sep 07	Option Exercise	0.00	600	0	4,891	Sep 09 09:38 AM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 07	Option Exercise	0.00	500	0	2,401	Sep 09 09:37 AM
Crowley Michael	EVP, GBL Commercial Operations	Sep 05	Option Exercise	0.00	600	0	5,069	Sep 08 12:10 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 05	Option Exercise	0.00	2,600	0	424,960	Sep 08 12:09 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 05	Option Exercise	0.00	500	0	2,149	Sep 08 12:05 PM
TUMOLO ANNETTE	Executive Vice President	Sep 05	Option Exercise	0.00	600	0	4,589	Sep 08 12:06 PM
TUMOLO ANNETTE	Executive Vice President	Sep 04	Option Exercise	0.00	600	0	4,287	Sep 08 12:06 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 04	Option Exercise	0.00	500	0	1,897	Sep 08 12:05 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 04	Option Exercise	0.00	2,600	0	423,650	Sep 08 12:09 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 04	Option Exercise	0.00	600	0	4,767	Sep 08 12:10 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 03	Option Exercise	0.00	557	0	4,444	Sep 08 12:10 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 03	Option Exercise	0.00	2,319	0	422,200	Sep 08 12:09 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 03	Option Exercise	0.00	464	0	1,619	Sep 08 12:05 PM
TUMOLO ANNETTE	Executive Vice President	Sep 03	Option Exercise	0.00	557	0	3,939	Sep 08 12:06 PM
Daskal Ilan	EVP, Chief Financial Officer	Sep 03	Sale	820.06	270	221,416	9	Sep 08 12:07 PM
SCHWARTZ NORMAN D	Chairman, President, and CEO	Sep 02	Option Exercise	0.00	1,805	0	420,776	Sep 03 05:12 PM
TUMOLO ANNETTE	Executive Vice President	Sep 02	Option Exercise	0.00	433	0	3,532	Sep 03 05:10 PM
Crowley Michael	EVP, GBL Commercial Operations	Sep 02	Option Exercise	0.00	433	0	4,102	Sep 03 05:09 PM
RAMALINGAM AJIT	SVP, Chief Accounting Officer	Sep 02	Option Exercise	0.00	240	0	473	Sep 03 05:07 PM
WRIGHT DARA	Executive Vice President	Sep 02	Option Exercise	0.00	433	0	761	Sep 03 05:08 PM
Last Andrew J.	EVP, Chief Operating Officer	Sep 02	Option Exercise	0.00	902	0	2,184	Sep 03 05:05 PM
Daskal Ilan	EVP, Chief Financial Officer	Sep 02	Option Exercise	261.91	1,081	283,122	548	Sep 03 05:02 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Sep 02	Option Exercise	0.00	361	0	1,280	Sep 03 05:01 PM
Daskal Ilan	EVP, Chief Financial Officer	Sep 02	Sale	828.00	540	447,121	7	Sep 03 05:02 PM
Last Andrew J.	EVP, Chief Operating Officer	Sep 01	Option Exercise	299.24	2,000	598,480	3,282	Sep 03 05:05 PM
Last Andrew J.	EVP, Chief Operating Officer	Sep 01	Sale	813.10	2,000	1,626,203	1,282	Sep 03 05:05 PM
TUMOLO ANNETTE	Executive Vice President	Aug 26	Sale	792.58	600	475,548	3,099	Aug 27 10:39 AM
Crowley Michael	EVP, GBL Commercial Operations	Aug 09	Option Exercise	139.56	3,000	418,680	6,669	Aug 10 11:58 AM
Crowley Michael	EVP, GBL Commercial Operations	Aug 09	Sale	754.93	3,000	2,264,796	3,669	Aug 10 11:58 AM
Daskal Ilan	EVP, Chief Financial Officer	Aug 04	Option Exercise	309.84	1,400	433,776	2,307	Aug 05 12:38 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Aug 04	Sale	760.26	327	248,605	919	Aug 05 12:40 PM
Daskal Ilan	EVP, Chief Financial Officer	Aug 04	Sale	751.84	2,300	1,729,241	7	Aug 05 12:38 PM
RAMALINGAM AJIT	SVP, Chief Accounting Officer	Apr 29	Option Exercise	0.00	276	0	318	May 03 01:48 PM
Last Andrew J.	EVP, Chief Operating Officer	Apr 29	Option Exercise	0.00	1,000	0	1,734	Apr 30 02:31 PM
Daskal Ilan	EVP, Chief Financial Officer	Apr 08	Option Exercise	0.00	700	0	1,157	Apr 09 11:38 AM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Feb 19	Option Exercise	159.32	400	63,728	2,143	Feb 22 04:05 PM
ERNST TIMOTHY S	EVP, General Counsel & Sec	Feb 19	Sale	640.77	923	591,499	1,220	Feb 22 04:05 PM
WRIGHT DARA	Executive Vice President	Dec 16	Option Exercise	0.00	502	0	502	Dec 17 04:34 PM
Crowley Michael	EVP, GBL Commercial Operations	Dec 15	Sale	580.67	374	217,171	3,669	Dec 17 12:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience